UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
AIT Therapeutics, Inc.
(Exact Name of Registrant as specified in its charter)
| Delaware | 47-3812456 | |
|
(State
or other Jurisdiction of
Incorporation or Organization) |
(I.R.S.
Employer
Identification No.) |
825 East Gate Blvd., Suite 320
Garden City, NY 11530
(Address of principal executive offices)
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title
of each class
to be so registered |
Name
of each exchange on which
each class is to be registered |
|
| Common Stock, $0.0001 par value | The Nasdaq Stock Market LLC |
If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. [X]
If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. [ ]
Securities Act registration statement file number to which this form relates: Not applicable.
Securities to be registered pursuant to Section 12(g) of the Act: None.
Item 1. Description of Registrant’s Securities to be Registered
The description of the common stock of AIT Therapeutics, Inc. (the “Registrant”), as set forth under the caption “Description of Securities” in the Company’s Registration Statement on Form S-1 (File No. 333-227681) filed with the Securities and Exchange Commission on October 3, 2018 (the “Registration Statement”), is incorporated herein by reference. In addition, any description of such securities contained in a form of prospectus relating to the Registration Statement subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.
Item 2. Exhibits
Under the instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| AIT THERAPEUTICS, INC. | ||
| Date: May 3, 2019 | By: | /s/ Steven Lisi |
| Name: | Steven Lisi | |
| Title: | Chief Executive Officer | |